Worried about your State Pension income? Here are 2 FTSE 100 dividend stocks I’d buy today

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver improving income returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the State Pension amounting to just £8,767 per year, many retirees are likely to need a second income in older age.

Since the FTSE 100 appears to offer good value for money at the present time, with it having a dividend yield of around 4.5%, there are a number of opportunities to generate a growing passive income across the large-cap share universe.

With that in mind, here are two FTSE 100 stocks that could offer an improving income outlook, as well as relatively stable financial performance over the long term.

AstraZeneca

It’s been a difficult journey for pharmaceutical company AstraZeneca (LSE: AZN) over the last decade. It has seen its profitability fall heavily due to the loss of patents on key drugs, with this leading to a lack of dividend growth in recent years.

Now though, the company appears to be in a relatively strong position. It has invested heavily in its pipeline under a strategy that has sought to focus on core growth areas. This strategy is now expected to bear fruit, with the business forecast to post a rise in net profit of around 12% in the current year.

This could stimulate AstraZeneca’s dividend growth prospects, and lead to an improving income outlook for its investors. It now has a dividend yield of just 3.4%, but its potential to increase dividends at a pace that exceeds inflation could lead to a robust outlook from an income perspective.

Alongside this, the company’s defensive appeal could help it to outperform the wider FTSE 100 at a time when the prospects for the global economy remain highly uncertain.

Unilever

Unilever’s (LSE: ULVR) recent updates have shown that its current growth strategy is paying off. It has focused investment on fast-growing markets across the emerging world, with them now making up the lion’s share of its revenue. They are also the main catalyst behind the company’s growth rate, and are likely to remain so over the medium term as wages in countries such as China move higher at a rapid rate.

Like AstraZeneca, Unilever’s dividend yield is below that of the wider FTSE 100 at the present time. The consumer goods company is set to record an income return of just 2.9% in the current year. However, with its bottom line forecast to produce a gain of 10% this year and its dividend payments being covered 1.6 times by profit, the scope for a rapidly-rising dividend seems to be high.

Although Unilever may lack the defensive appeal of some of its FTSE 100 peers, its potential to enjoy above-average growth over the long run seems to be high. It has a wide range of popular brands in a number of different markets. This provides it with a wide economic moat which, alongside its growth potential, makes it an enticing income opportunity for the long term.

Peter Stephens owns shares of AstraZeneca and Unilever. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

£10k invested in sizzling Barclays, Lloyds and NatWest shares 1 year ago is now worth…

Harvey Jones is blown away by the performance of NatWest shares and the other FTSE 100 banks over the last…

Read more »

Investing Articles

£5,000 invested in these 3 UK stocks at the start of 2025 is now worth…

Mark Hartley breaks down the growth of three UK stocks that helped drive the FTSE 100 to new highs this…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Time to start preparing for a stock market crash?

2025's been an uneven year on stock markets. This writer is not trying to time the next stock market crash…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Nvidia stock’s had a great 2025. Can it keep going?

Christopher Ruane sees an argument for Nvidia stock's positive momentum to continue -- and another for the share price to…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

£20,000 in savings? Here’s how someone could aim to turn that into a £10,958 annual second income!

Earning a second income doesn't necessarily mean doing more work. Christopher Ruane highlights one long-term approach based on owning dividend…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

My favourite FTSE value stock falls another 6% on today’s results – should I buy more?

Harvey Jones highlights a FTSE 100 value stock that he used to consider boring, but has been surprisingly volatile lately.…

Read more »

UK supporters with flag
Investing Articles

See what £10,000 invested in the FTSE 100 at the start of 2025 is worth today…

Harvey Jones is thrilled by the stunning performance of the FTSE 100, but says he's having a lot more fun…

Read more »

Investing Articles

Prediction: here’s where the latest forecasts show the Vodafone share price going next

With the Vodafone turnaround strategy progressing, strong cash flow forecasts could be the key share price driver for the next…

Read more »